CLL-IPI applied in Binet A CLL: a nationwide cohort study

Emelie C. Rotbain; Caspar da Cunha-Bang; Christian Brieghel; Carsten U. Niemann

doi:10.1182/bloodadvances.2021006259

CLL-IPI applied in Binet A CLL: a nationwide cohort study

Emelie C. Rotbain^*, Caspar da Cunha-Bang, Christian Brieghel, Carsten U. Niemann

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Letter › peer review

4 Citationer (Scopus)

12 Downloads (Pure)

Originalsprog	Engelsk
Tidsskrift	Blood advances
Vol/bind	6
Udgave nummer	21
Sider (fra-til)	5698-5701
Antal sider	4
ISSN	2473-9529
DOI	https://doi.org/10.1182/bloodadvances.2021006259
Status	Udgivet - 2022

Bibliografisk note

Funding Information:
This work was supported in part by Novo Nordisk Foundation grant NNF16OC0019302 (C.U.N.).

Adgang til dokumentet

10.1182/bloodadvances.2021006259Licens: CC BY-NC-ND

FulltextForlagets udgivne version, 236 KBLicens: CC BY-NC-ND

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

@article{e135a88546c14035bbb418932a58b232,

title = "CLL-IPI applied in Binet A CLL: a nationwide cohort study",

author = "Rotbain, {Emelie C.} and {da Cunha-Bang}, Caspar and Christian Brieghel and Niemann, {Carsten U.}",

note = "Funding Information: This work was supported in part by Novo Nordisk Foundation grant NNF16OC0019302 (C.U.N.).",

year = "2022",

doi = "10.1182/bloodadvances.2021006259",

language = "English",

volume = "6",

pages = "5698--5701",

journal = "Blood advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "21",

}

TY - JOUR

T1 - CLL-IPI applied in Binet A CLL

T2 - a nationwide cohort study

AU - Rotbain, Emelie C.

AU - da Cunha-Bang, Caspar

AU - Brieghel, Christian

AU - Niemann, Carsten U.

N1 - Funding Information: This work was supported in part by Novo Nordisk Foundation grant NNF16OC0019302 (C.U.N.).

PY - 2022

Y1 - 2022

U2 - 10.1182/bloodadvances.2021006259

DO - 10.1182/bloodadvances.2021006259

M3 - Letter

C2 - 35090168

AN - SCOPUS:85142048571

SN - 2473-9529

VL - 6

SP - 5698

EP - 5701

JO - Blood advances

JF - Blood advances

IS - 21

ER -